Author/Editor		Rizvi, Ali A.; Popovic, Djordje S.; Papanas, Nikolaos; Pantea Stoian, Anca; Mahmeed, Wael Al; Sahebkar, Amirhossein; Janež, Andrej; Rizzo, Manfredi
Title		Current and emerging drugs for the treatment of atherosclerosis
Type		članek
Publication year		2022
Volume		str. str.
ISSN		1477-9072 - Expert review of cardiovascular therapy
Language		eng
Abstract		Atherosclerosis can be considered a chronic inflammatory process that stands out as a dominant cause of cardiovascular disease (CVD). Since blood lipids are the leading risk factor for atherosclerosis development, lowering low-density lipoprotein cholesterol (LDL-C) and other apolipoprotein B-containing lipoproteins reduces the risk of future cardiovascular events. However, there has been significant progress in developing lipid-lowering drugs for aggressive management of dyslipidemia, the rates of CVD events remain unacceptably high, so there is great need to identify novel therapeutic pathways targeting the atherosclerosis process.
Keywords		atherosclerosis lipoproteins developing drugs ateroskleroza lipoproteini razvoj zdravil